Skip to main content

Washington State Bills Seek to Legalize Psychedelics for Therapeutic Use

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

A pair of bills filed in the Washington State legislature seeks to legalize psychedelics, particularly psilocin and psilocybin, for medicinal purposes in clinical settings. One bill was filed in the state senate while the other was filed in the assembly. Both bills seek to legalize these hallucinogens for adults aged 21 or older.

The work that startups like Compass Pathways PLC (NASDAQ: CMPS) are doing is in part motivated by…

Read More>>

About PsychedelicNewsWire

PsychedelicNewsWire (“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

PsychedelicNewsWire
San Francisco, CA
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicNewsWire.com

PsychedelicNewsWire is powered by IBN

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.70
+0.00 (0.00%)
AAPL  263.40
+0.00 (0.00%)
AMD  278.26
+0.00 (0.00%)
BAC  53.51
+0.00 (0.00%)
GOOG  332.77
+0.00 (0.00%)
META  676.87
+0.00 (0.00%)
MSFT  420.26
+0.00 (0.00%)
NVDA  198.35
+0.00 (0.00%)
ORCL  178.34
+0.00 (0.00%)
TSLA  388.90
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.